Replies to post #11849 on The Rising Influence of Rising Affluence

[jbog]

We've done a lot of work over the last couple of years on Revance's factory build out for their injectables. First class operation.

I feel they can do very well with just sitting in Allergan's shadow.

I bought a little early in May 14' and was able to avg down in Jan 15' so I'm probably even right about now.

Good Luck

I'm not one for IPO's but a couple are of interest if the markets calm down this year. I expect these 3 will be interesting when they come out:

1) Patheon Inc.
2) Editas Medicine Inc
3) Samsung Bioepis